| Mepha Pharma AG - Rivaroxaban-Mepha vascular 2.5 mg Filmtabletten | | 68440 | | 01 | | Rivaroxaban-Mepha vascular 2.5 mg Filmtabletten | | | | B01AF01 | | Rivaroxaban | | 06.04.2022 | | |
| | Composition | | rivaroxabanum 2.5 mg, natrii laurilsulfas, lactosum monohydricum 184.7 mg, hypromellosum, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (flavum), pro compresso obducto corresp. natrium max. 1.19 mg. | | Packungsbestandteile | | Active Agent | Dose |
|---|
| Rivaroxabanum | 2.5 mg |
| | BAG: Active Agent | Dose |
|---|
| Rivaroxabanum | 2.5 mg |
| | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | Carmellosum Natricum Conexum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | | | Lactose Monohydrate | 184.7 mg | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Talcum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 56 | 28.70 | 47.65 | B | SL | Yes | | 002 | 196 | 100.46 | 125.65 | B | SL | Yes | | 003 | 100 | 51.25 | 72.15 | B | SL | Yes |
|
|
